Dr. Christopher Myers

Dr. Christopher Myers serves as Principal Investigator at the Naval Medical Research Center, where he leads the scientific design and technical validation of biomedical research initiatives critical to force health protection. In this role, he acts as the primary technical authority for acquisition requirements, bridging operational medical needs with R&D execution to ensure field-deployable diagnostics and analytical tools meet military readiness standards. He typically oversees sole-source and competitive research contracts for advanced laboratory systems, infectious disease detection platforms, and point-of-care diagnostic technologies, ensuring alignment with the Center’s mission to safeguard Navy and Marine Corps personnel in austere environments. Dr. Myers maintains a consistent working relationship with REES SCIENTIFIC CORPORATION, a trusted partner in the development and validation of specialized biomedical instrumentation and diagnostic assays. His procurement approach emphasizes deep technical collaboration, often involving co-development agreements and prototype-to-production transitions with vendors possessing niche expertise in molecular diagnostics, biosensor integration, and field-deployable lab systems. These partnerships are characterized by long-term technical engagement rather than transactional procurement, reflecting a research-driven acquisition philosophy. Dr. Myers’ contracting activity reflects no set-aside preferences, with 100% of awards issued under full and open competition. This indicates a primary focus on technical capability and scientific merit over socioeconomic criteria, prioritizing mission-critical performance over vendor classification. While small business participation is not formally mandated, his selections are driven by the unique technical qualifications required to meet complex biomedical research objectives. His procurement activity is exclusively focused on NAICS 541712—Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology). He specializes in acquiring advanced diagnostic platforms, pathogen detection systems, and laboratory automation tools, with deep expertise in molecular biology, point-of-care diagnostics, and field-deployable analytical technologies essential for operational medicine.